Sensitivity of the Multispot HIV-1/HIV-2 Rapid Test Using Samples from Human Immunodeficiency Virus Type 1-Positive Individuals with Various Levels of Exposure to Highly Active Antiretroviral Therapy
Journal of Clinical MicrobiologyPublished 1 May 2006Open access
Robert J. O’Connell, Brian K. Agan, Stephanie A. Anderson, Jennifer Malia, Nelson L. Michael
Citations22
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The Multispot HIV-1/H HIV-2 rapid test detects human immunodeficiency virus type 1 (HIV-1) gp41 antibodies, which can wane over time in some HIV- 1-infected populations, resulting in false-negative screening results.
Abstract
The Multispot HIV-1/HIV-2 rapid test detects human immunodeficiency virus type 1 (HIV-1) gp41 antibodies, which can wane over time in some HIV-1-infected populations, resulting in false-negative screening results. Multispot sensitivity was 100% using 248 sera from one such population, and it correctly identified serostatus in individuals who previously tested false negative with rapid testing.
Keywords
Immunology and MicrobiologyMedicine
Nature MedicineHIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
748 Citations1999Christine J. Pitcher, Claudia Quittner +5 more
Functional HIV-1-specific CD4+ T cells are commonly available for support of anti-HIV-1 effector responses in active disease, but their decline with anti-retroviral therapy indicates that immunologic participation in long-term HIV- 1 control will probably require effective vaccination strategies.
The Journal of Experimental MedicineHIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy
250 Citations1998Lynn Morris, James Μ. Binley +9 more
It is concluded that HIV-1 infection drives B cell hyperactivity, and that this polyclonal activation is rapidly responsive to decreases in viral replication caused by combination antiviral therapy.
Journal of Clinical MicrobiologyPerformance of the OraQuick Rapid Antibody Test for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Patients with Various Levels of Exposure to Highly Active Antiretroviral Therapy
101 Citations2003Robert J. O’Connell, Teresa Merritt +8 more
The OraQuick HIV-1 test demonstrated 100% specificity and 96% sensitivity and four false-negative subjects, who were characterized by early initiation of effective antiretroviral therapy, demonstrated waning serum anti-gp41 titers and Western blot band intensities.
Clinical ChemistryImmunoConcentration--a new format for solid-phase immunoassays.
66 Citations1985G E Valkirs, Richard Barton
A new format for solid-phase immunoassays has been developed in which a monoclonal antibody-coated membrane, incorporated into a cylindrical, disposable device, regulates sample and reagent delivery and the high ratio of surface area to volume within the microporous matrix of the membrane assures short diffusion distances and therefore rapid binding of liquid-phase reagents to the solid phase.
Expert Review of Molecular DiagnosticsOraQuick® ADVANCE Rapid HIV-1/2 antibody test
54 Citations2004Steven J. Reynolds, Jérémie Muwonga
Clinical evaluation of the OraQuick ADVANCE Rapid HIV-1/2 antibody test has revealed high sensitivity and specificity and has many important applications, extending the opportunities for voluntary counseling and testing, and as a tool for the scale-up of antiretroviral therapy in resource-limited settings.
Clinical and Diagnostic Laboratory ImmunologyDiagnosis of Human Immunodeficiency Virus Type 1 Infection with Different Subtypes Using Rapid Tests
52 Citations2000Susan Phillips, Timothy C. Granade +4 more
The results suggest that although rapid tests perform well in general, it may be prudent to evaluate a rapid test for sensitivity and specificity in a local population prior to its widespread use.
AIDS Research and Human RetrovirusesSelective Increases in HIV-Specific Neutralizing Antibody and Partial Reconstitution of Cellular Immune Responses during Prolonged, Successful Drug Therapy of HIV Infection
24 Citations2001Jerome H. Kim, John R. Mascola +11 more
In the setting of stable anti-HIV Ab levels, the development of increased NAb in certain individuals suggests that control of the virus by HAART may assist in immune control of HIV.
Journal of Virological MethodsEvaluation of three rapid tests for detection of antibodies to HIV-1 non-B subtypes
21 Citations2003África Holguín
Three rapid tests were evaluated for the detection of antibodies to HIV in 111 plasma specimens (81 HIV-1 non-B subtypes, including 4 coinfections with HIV-2, 30 HIV negative) and the Determine HIV/2, Equipar HIV, and Multispot HIV/1/2 tests were 100% sensitive and specific.
American Journal of PerinatologyPilot Study of Expedited HIV-1 Testing of Women in Labor at an Inner-City Hospital in New York City
16 Citations2001Mayris P. Webber, Penelope Demas +5 more
It appears that the accuracy of rapid and expedited HIV assays may be improved by requiring two different reactive assays before informing women of HIV-seropositive results or initiating antiretroviral treatment.